Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Escalate
Trigeminal neuralgia is not usually an emergency, but new facial pain with vesicles near the eye, visual symptoms, temporal-artery tenderness, stroke signs, spreading dental or facial infection, meningism or acute angle-closure glaucoma needs same-day assessment. Inability to eat or drink because every stimulus triggers pain can rapidly cause dehydration and may require urgent specialist support.
Synopsis
Identify the distinctive paroxysmal facial-pain syndrome, detect secondary causes and dangerous mimics, and use carbamazepine and neurosurgical referral safely within current specialist pathways.
Trigeminal neuralgia causes recurrent unilateral electric-shock, stabbing or shooting pain in one or more trigeminal divisions, most often maxillary or mandibular, lasting a fraction of a second to about two minutes.
Innocuous triggers such as light touch, talking, chewing, tooth brushing, shaving or a breeze are characteristic; patients may identify a small trigger zone and pause during attacks.
Classical disease is associated with neurovascular compression that produces morphological change of the trigeminal root; secondary disease arises from multiple sclerosis, tumour or another structural lesion.
Key red flags
Severe flare
Repeated triggers can make swallowing, drinking and oral hygiene impossible, causing dehydration, weight loss and psychological crisis despite a normal examination.
Investigation priorities
01
Structured pain historyFirst step
Test the syndrome against recognised diagnostic features and common mimics.
Management branches
Clinical diagnosisConfirm phenotype and exclude urgency
A patient reports recurrent unilateral episodes of severe facial pain.
Characterise each attack's quality, duration, distribution and triggers, then ask about rash, vision, dental symptoms, jaw pain, temporal tenderness and cranial autonomic features.
Examine oral structures, temporomandibular joints, trigeminal sensation and the remaining cranial nerves, escalating infection, ocular disease, vasculitis or neurological deficit appropriately.
Poor controlEscalate refractory or intolerant disease
Adequately titrated first-line therapy fails, toxicity occurs or nutrition is threatened.
Key medicines
CarbamazepineA common oral introduction is 100 mg once or twice daily with gradual increments; use the current BNF regimen, lowest effective dose and individualised maximum rather than a fixed template.
OxcarbazepineSpecialists often begin a low divided oral dose and titrate against attacks; exact use follows the local formulary because trigeminal-neuralgia prescribing may be off label.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.